Related Experiment Video
Updated: Jun 9, 2025

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
SF3B4 Regulates Cellular Senescence and Suppresses Therapy-induced Senescence of Cancer Cells
Seungyeon Yang1,2, Minbeom Ko1,2, Soojung Claire Hur3
1Department of Biochemistry, Institute for Aging and Metabolic Diseases, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Background/Aim:
Cellular senescence is a state in which cells permanently exit the cell cycle, preventing tumor growth, but it can also contribute to aging and chronic inflammation. Senescence induced by cancer therapies, known as therapy-induced senescence (TIS), halts cancer cell proliferation and prevents metastasis. TIS has been investigated as an important therapeutic approach that could minimize cytotoxicity effects. This study aimed to elucidate the role of splicing factor 3B subunit 4 (SF3B4) in cellular senescence and TIS in cancer cells.
Materials And Methods:
β-galactosidase staining was used to examine senescence induction. SF3B4 and p21 expression were determined by RT-qPCR and western blot. Cell proliferation and cell death were evaluated.
Results:
SF3B4 expression decreases in replicative senescent human fibroblasts and its knockdown induces senescence via a p21-dependent pathway. In A549 non-small cell lung cancer (NSCLC) cells, SF3B4 knockdown also increased senescence markers. Notably, SF3B4 overexpression mitigated doxorubicin-induced senescence in A549 cells.
Conclusion:
SF3B4 regulates senescence, and this study highlights its potential as a therapeutic target for developing better cancer treatment strategies by leveraging TIS to suppress tumor growth and enhance treatment efficacy.
Insights
Splicing factor SF3B4 regulates cellular senescence. Its reduction induces senescence, while its overexpression mitigates therapy-induced senescence (TIS) in cancer cells, suggesting SF3B4 as a therapeutic target for cancer treatment.
Area of Science:
- Cellular biology
- Cancer research
- Molecular oncology
Background:
- Cellular senescence is a permanent cell cycle exit that prevents tumor growth but contributes to aging and inflammation.
- Therapy-induced senescence (TIS) halts cancer cell proliferation and metastasis, offering a therapeutic strategy with minimized cytotoxicity.
- Understanding the regulators of senescence is crucial for developing effective cancer treatments.
Purpose of the Study:
- To investigate the role of splicing factor 3B subunit 4 (SF3B4) in regulating cellular senescence.
- To determine the involvement of SF3B4 in therapy-induced senescence (TIS) in cancer cells.
- To explore SF3B4 as a potential therapeutic target for cancer treatment.
Main Methods:
- Senescence induction was assessed using beta-galactosidase staining.
- SF3B4 and p21 expression levels were quantified via RT-qPCR and western blotting.
- Cell proliferation and cell death assays were performed to evaluate functional outcomes.
Main Results:
- SF3B4 expression was found to decrease in senescent human fibroblasts.
- Knockdown of SF3B4 induced senescence through a p21-dependent pathway in both fibroblasts and A549 non-small cell lung cancer (NSCLC) cells.
- Overexpression of SF3B4 attenuated doxorubicin-induced senescence in A549 NSCLC cells.
Conclusions:
- SF3B4 plays a significant role in regulating cellular senescence.
- The findings suggest SF3B4 as a potential therapeutic target for enhancing cancer treatment efficacy through TIS.
- Targeting SF3B4 could offer a novel strategy to suppress tumor growth and improve treatment outcomes.
More Related Videos
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
Related Concept Videos
Replicative Cell Senescence
Negative Regulator Molecules
Abnormal Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
The Intrinsic Apoptotic Pathway
Regulation of Hematopoietic Stem Cells